Founded in Houston, United States, TomoWave Laboratories is dedicated to pioneering advancements in medical imaging technology. The company's core mission is to enhance cancer detection and image-guided interventions through the development of proprietary optoacoustic tomography and laser ultrasound systems. These systems combine functional, molecular, and anatomical imaging by leveraging the principles of depth-resolved optoacoustics, offering a significant improvement over traditional imaging methods.

TomoWave Laboratories has garnered attention from notable figures in the medical and scientific communities, as well as from key investors who recognize the transformative potential of their technology. The company's achievements include the successful development and deployment of advanced imaging systems that have shown promise in early cancer detection and precision-guided treatments. Through its innovative approach, TomoWave is making a substantial impact on the field of medical imaging, potentially improving patient outcomes and advancing the capabilities of diagnostic technologies.